arrow
R

Rebecca Jane Cox

university of bergen
H指数:44
被引数:8,280

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of an Inactivated Quadrivalent Influenza Vaccine in Children and Pregnant Women in Rural Bangladesh: A Phase IV Double-Blind, Cluster-Randomized Trial

在孟加拉国农村儿童和孕妇中四价灭活流感疫苗的有效性:一项IV期双盲、整群随机试验

2026-10-260
OA
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)

一项提前终止的2期、随机临床试验,旨在评估先前感染过SARS-CoV-2的5-11岁儿童接种mRNA疫苗BNT162b2时,单剂次与两剂次基础免疫程序在免疫原性和不良反应方面的比较(CoVacc试验)

Vaccine
IF3.5
2026-06-010
OAAI
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report
2026-02-060
OAAI
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial

随机对照试验:奈玛特韦/利托那韦与安慰剂对照,用于预防急性COVID-19成人患者长新冠——PanoramicNOR试验

2025-11-060
OAAI
Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens

双价mRNA加强疫苗接种可重新激活针对抗原性分化的SARS-CoV-2刺突抗原的细胞免疫和抗体免疫。

2025-04-180
OA
Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
2025-02-060
OAAI